Running the Wolverine Stack without bloodwork means guessing whether BPC-157 + TB-500 is actually doing anything. Subjective improvements — less pain, better mobility, faster recovery — are real but unreliable. Inflammation markers, liver safety, and immune function give you the objective picture.
This guide covers the 6 labs that matter most for a BPC-157 + TB-500 protocol: what to test, when to test it, what optimal ranges look like, and when results should change your protocol.
Testing Schedule
Baseline (1-2 weeks before starting): Run all 6 labs. This is your reference point for everything.
Mid-cycle (weeks 4-6): Retest hs-CRP, ESR, and liver panel. Inflammatory markers should be trending down. Liver values confirm safety.
Post-cycle (2-4 weeks after finishing): Retest everything. This shows what improvements persisted and what bounced back.
Lab 1: hs-CRP (Inflammation Tracking)
Why it matters: High-sensitivity C-reactive protein is the single most useful marker for tracking the Wolverine Stack. Both BPC-157 and TB-500 have anti-inflammatory mechanisms — BPC-157 through nitric oxide modulation and TB-500 through local cytokine regulation. If these peptides are working, hs-CRP should trend downward.
| Range |
Interpretation |
| < 0.5 mg/L |
Optimal — minimal systemic inflammation |
| 0.5-1.0 mg/L |
Good — low cardiovascular risk |
| 1.0-3.0 mg/L |
Average — room for improvement |
| > 3.0 mg/L |
Elevated — significant inflammation |
| > 10 mg/L |
High — acute inflammation or infection |
What to expect: Users with elevated baseline hs-CRP (>1.0) often see a 20-40% reduction by weeks 4-6. If hs-CRP doesn't move at all after 6 weeks, the stack may not be addressing your primary inflammatory driver.
Testing note: hs-CRP can spike from acute illness, intense exercise, or injury. Test when healthy and rested for accurate results.
Lab 2: ESR (Secondary Inflammation Marker)
Why it matters: Erythrocyte sedimentation rate provides a second inflammation read that captures different inflammatory processes than CRP. While CRP responds to acute-phase proteins, ESR reflects chronic, low-grade inflammation more reliably.
| Range (Male) |
Range (Female) |
Interpretation |
| < 10 mm/hr |
< 15 mm/hr |
Optimal |
| 10-15 mm/hr |
15-20 mm/hr |
Normal |
| 15-20 mm/hr |
20-30 mm/hr |
Mildly elevated |
| > 20 mm/hr |
> 30 mm/hr |
Elevated — investigate |
What to expect: ESR moves more slowly than CRP. Meaningful changes typically appear by weeks 6-8. If CRP drops but ESR stays elevated, there may be a chronic inflammatory process that BPC-157/TB-500 isn't fully addressing.
Lab 3: Liver Panel (ALT + AST)
Why it matters: Standard safety monitoring for any exogenous peptide. Both BPC-157 and TB-500 are processed systemically, and liver enzymes confirm you're not creating hepatic stress. BPC-157 has actually demonstrated hepatoprotective effects in animal studies, so liver values may improve during a cycle.
| Marker |
Optimal |
Normal Range |
Concern |
| ALT |
10-30 U/L |
< 40 U/L |
> 50 U/L |
| AST |
10-30 U/L |
< 40 U/L |
> 50 U/L |
What to expect: Liver enzymes should remain stable or improve slightly. If ALT or AST rises above 50 U/L during a cycle, pause the protocol and retest in 2 weeks. Persistent elevation warrants physician evaluation.
Note: Intense exercise can elevate AST (it's also in muscle tissue). Test in a rested state, 48+ hours after heavy training.
Lab 4: CBC with Differential
Why it matters: Complete blood count with differential tracks immune system function. TB-500's parent protein (thymosin beta-4) is produced by the thymus and plays a role in T-cell development. Monitoring white blood cell counts and differential ensures the immune system isn't being over-stimulated or suppressed.
| Marker |
Optimal Range |
Concern |
| WBC |
4.0-8.0 x10^3/uL |
< 3.5 or > 11.0 |
| Neutrophils |
40-60% |
> 70% or < 35% |
| Lymphocytes |
20-40% |
> 50% or < 15% |
| Platelets |
150-400 x10^3/uL |
< 100 or > 450 |
What to expect: CBC should remain within normal limits throughout a Wolverine Stack cycle. Significant shifts in WBC count or differential could indicate immune dysregulation — unlikely but worth monitoring given TB-500's thymic origin.
Lab 5: IGF-1 (Growth Factor Monitoring)
Why it matters: BPC-157 and TB-500 do not directly affect IGF-1. However, many users stack the Wolverine Stack with GH-releasing peptides (Ipamorelin, CJC-1295) or GH secretagogues (MK-677). If you're stacking, IGF-1 monitoring is essential to ensure growth hormone levels stay within safe ranges.
| Range |
Interpretation |
| 100-250 ng/mL |
Normal (age-dependent) |
| 250-350 ng/mL |
Elevated — may be fine if using GH peptides |
| > 350 ng/mL |
High — consider reducing GH peptide dose |
If not stacking: You can skip this test. BPC-157 and TB-500 alone should not meaningfully alter IGF-1.
If stacking with GH peptides: Test baseline and at weeks 4-6. IGF-1 above 350 ng/mL warrants dose reduction of the GH component.
Lab 6: P1NP (Tissue Repair Marker)
Why it matters: Procollagen type I N-terminal propeptide (P1NP) is a direct marker of collagen synthesis — essentially a readout of how actively your body is building new connective tissue. Both BPC-157 (via growth factor activation) and TB-500 (via cell migration to repair sites) should support increased collagen formation.
| Range |
Interpretation |
| 25-100 ng/mL |
Normal (age/sex dependent) |
| > 100 ng/mL |
Active tissue remodeling |
| Significant increase from baseline |
Healing peptides are working |
What to expect: P1NP should increase from baseline during an active healing protocol. A 20-50% increase suggests active tissue remodeling. If P1NP doesn't budge after 6 weeks, the healing response may be insufficient — consider dose adjustment or protocol review.
Testing note: P1NP is not a standard lab. Request it specifically or order through a specialty lab panel.
Interpreting Your Results
Best Case Scenario
- hs-CRP drops 20-40% from baseline
- ESR trends downward
- Liver enzymes stable or improved
- CBC unchanged
- P1NP increases (active tissue repair)
Concerning Patterns
- hs-CRP increases during cycle — may indicate infection or tissue stress, not peptide-related
- ALT/AST rises above 50 — pause protocol, retest in 2 weeks
- WBC count drops below 3.5 or rises above 11 — discontinue and consult physician
- Any unexpected lab shift that doesn't resolve within 2 weeks
When Bloodwork Should Change Your Protocol
| Lab Finding |
Action |
| hs-CRP rising |
Investigate other causes (infection, overtraining) — not typical of Wolverine Stack |
| ALT > 50 U/L |
Pause protocol 2 weeks, retest. If normalized, resume at lower dose |
| ALT > 100 U/L |
Discontinue, consult physician |
| WBC < 3.5 or > 11 |
Discontinue, consult physician |
| IGF-1 > 350 (if stacking) |
Reduce GH peptide dose |
| No change in P1NP after 8 weeks |
Reassess dose, protocol adherence, or whether the stack targets your specific issue |
When to Stop Based on Bloodwork
Red flags that mean discontinue immediately and consult a physician:
- ALT or AST > 3x upper limit (>120 U/L) — potential liver damage
- WBC < 2.5 x10^3/uL — immune suppression risk
- Platelets < 100 x10^3/uL — bleeding risk
- Any rapidly worsening lab value between tests
These scenarios are rare with the Wolverine Stack — BPC-157 has shown no hepatotoxicity in clinical trials and TB-500 hasn't demonstrated immune suppression in animal studies. But monitoring catches problems before they become serious.
Frequently Asked Questions
Do I need bloodwork before starting the Wolverine Stack?
Strongly recommended. Baseline labs give you objective data to measure whether BPC-157 + TB-500 is actually working. Without pre-cycle numbers, you're relying entirely on subjective assessment.
What's the most important blood test for the Wolverine Stack?
hs-CRP (high-sensitivity C-reactive protein). It's the broadest indicator of systemic inflammation and the marker most likely to show measurable improvement during a healing peptide protocol.
Will BPC-157 or TB-500 show up on blood tests?
Neither peptide appears on standard blood panels. They're not included in routine lab work. However, their effects will show as changes in inflammatory markers, liver values, and tissue repair indicators.
How often should I retest during a Wolverine Stack cycle?
Baseline before starting, mid-cycle at weeks 4-6 (inflammatory markers), and post-cycle 2-4 weeks after finishing. Three panels total gives you the full picture.
Should I check IGF-1 on the Wolverine Stack?
Only if you're stacking with GH-releasing peptides (Ipamorelin, CJC-1295, MK-677). BPC-157 and TB-500 alone should not significantly affect IGF-1 levels.
References
- Sikiric, P., et al. (2014). BPC-157 and nitric oxide system interaction. Current Pharmaceutical Design, 20(7), 1126-1135. PMID: 23755725
- Seiwerth, S., et al. (2014). BPC 157 and wound healing. PMID: 23782145
- Sosne, G., et al. (2010). Thymosin beta 4 and anti-inflammatory wound healing. Investigative Ophthalmology & Visual Science, 51(11), 6012-6017. PMID: 20207966
- Malinda, K.M., et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 113(3), 364-368. PMID: 10469335
- Philp, D., et al. (2004). Thymosin beta4 promotes angiogenesis and wound healing. Mechanisms of Ageing and Development, 125(2), 113-115. PMID: 15037013
This article is for educational and informational purposes only. It is not medical advice. The Wolverine Stack (BPC-157 + TB-500) is sold as a research compound and is not FDA-approved for human use. Consult a qualified healthcare provider before starting any peptide protocol.